Main research projects:

  • Developing novel AI methods to predict antimicrobial resistance by integrating Genomics and Public Health data; enhancing scalability and application over multiple sequencing technologies (Illumna, PacBio, ONT)
  • Understanding the molecular mechanisms underpinning the anti-inflammatory effects of cannabionoids at the single-cell level, and their interplay at the physiological (macro) level
  • Developing tailored, versatile, and scalable AI approach to predict viral phenotypes and evolution

Recent Funding

  • NIH NIA 1R21AG088603 ($409,574) 09/2024 – 08/2026. Contact PI Marini. MPIs: Wang, Sibille. Medical Marijuana and chronic musculoskeletal pain in older adults: a multi-level, precision medicine analysis
  • MERCK AND COMPANY INC RES LAB ($350,150) 10/2024 – 10/2026. Contact PI Marini. MPIs: Czyz, Cherabuddi. Genomic characterization of antimicrobial resistance and viral co-infection patterns of Streptococcus pneumoniae by next-generation sequencing and artificial intelligence
  • MERCK AND COMPANY INC RES LAB ($249,629.85) [Grant accepted; contract under negotiation] Contact PI Marini. MPIs: Mavia, Hitchings. Causal AI for Predictive Modeling of Dengue Trajectories: A Comprehensive Approach Considering Climate Variability and Intervention Strategies
  • AI and Complex Computational Research Award, NVIDIA UF ($61,652) 09/2024 – 03/2025 Contact PI Marini. ViraLingo: decoding pan-viral genomics with AI